Skip to main content
Top
Published in: Cancer Causes & Control 8/2010

01-08-2010 | Original paper

A case–control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults

Authors: Jennifer L. Kelly, Jonathan W. Friedberg, Laura M. Calvi, Edwin van Wijngaarden, Susan G. Fisher

Published in: Cancer Causes & Control | Issue 8/2010

Login to get access

Abstract

Recent research suggests that ultraviolet radiation exposure (UVRE), our major source of vitamin D, is associated with reduced lymphoma risk. Animal and human studies support an association between vitamin D (vitD) insufficiency and increased risk of some malignancies. We conducted a clinic-based case–control study (140 lymphoma cases, 139 controls; 2002–2005, Rochester, NY) to evaluate UVRE and vitD insufficiency in relation to lymphoma risk. Subjects completed a survey and provided a blood sample. We used multivariable logistic regression to estimate lymphoma risk in relation to past (5–10 years prior) UVRE and current vitD insufficiency (determined by serum 25(OH)D). Possible differences in effect by lymphoma subtype were explored, but statistical power was limited. We confirmed the previously reported decrease in lymphoma risk with past UVRE, specifically sunbathing (>once/week versus never); adjusted odds ratio (ORadj), = 0.28, 95% confidence interval (CI): 0.10–0.79. Current vitD insufficiency was not associated with lymphoma risk (ORadj = 0.89, 95% CI: 0.47–1.72). However, current sunbathing frequency was correlated with measured serum 25(OH)D values. Therefore, while our data do not support an association with current vitD status, development of accurate methods for past vitD assessment to further investigate its role in the association between past UVRE and lymphoma risk is warranted.
Literature
2.
go back to reference Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23(38):6524–6534CrossRefPubMed Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin’s lymphoma. Oncogene 23(38):6524–6534CrossRefPubMed
3.
go back to reference Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84(1):1–12CrossRefPubMed Muller AM, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 84(1):1–12CrossRefPubMed
4.
go back to reference Hartge P, Lim U, Freedman DM et al (2006) Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 17(8):1045–1052CrossRefPubMed Hartge P, Lim U, Freedman DM et al (2006) Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 17(8):1045–1052CrossRefPubMed
5.
go back to reference Soni LK, Hou L, Gapstur SM et al (2007) Sun exposure and non-Hodgkin lymphoma: A population-based, case-control study. Eur J Cancer 43(16):2388–2395CrossRefPubMed Soni LK, Hou L, Gapstur SM et al (2007) Sun exposure and non-Hodgkin lymphoma: A population-based, case-control study. Eur J Cancer 43(16):2388–2395CrossRefPubMed
6.
go back to reference Weihkopf T, Becker N, Nieters A et al (2007) Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer 120(11):2445–2451CrossRefPubMed Weihkopf T, Becker N, Nieters A et al (2007) Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer 120(11):2445–2451CrossRefPubMed
7.
go back to reference Hughes AM, Armstrong BK, Vajdic CM et al (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 112(5):865–871CrossRefPubMed Hughes AM, Armstrong BK, Vajdic CM et al (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 112(5):865–871CrossRefPubMed
8.
go back to reference Smedby KE, Hjalgrim H, Melbye M et al (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97(3):199–209CrossRefPubMed Smedby KE, Hjalgrim H, Melbye M et al (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97(3):199–209CrossRefPubMed
9.
go back to reference Armstrong BK, Kricker A (2007) Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):396–400CrossRefPubMed Armstrong BK, Kricker A (2007) Sun exposure and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):396–400CrossRefPubMed
10.
go back to reference Kricker A, Armstrong BK, Hughes AM et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 122(1):144–154CrossRefPubMed Kricker A, Armstrong BK, Hughes AM et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 122(1):144–154CrossRefPubMed
11.
go back to reference Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688SPubMed Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S–1688SPubMed
12.
go back to reference Ginde AA, Liu MC, Camargo CA Jr (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 169(6):626–632CrossRefPubMed Ginde AA, Liu MC, Camargo CA Jr (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 169(6):626–632CrossRefPubMed
13.
go back to reference Schwartz GG, Skinner HG (2007) Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care 10(1):6–11PubMed Schwartz GG, Skinner HG (2007) Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care 10(1):6–11PubMed
14.
go back to reference Egan KM, Sosman JA, Blot WJ (2005) Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst 97(3):161–163CrossRefPubMed Egan KM, Sosman JA, Blot WJ (2005) Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst 97(3):161–163CrossRefPubMed
15.
go back to reference Holick MF (2008) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19(2):73–78CrossRefPubMed Holick MF (2008) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19(2):73–78CrossRefPubMed
17.
go back to reference Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79(3):362–371PubMed Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79(3):362–371PubMed
18.
go back to reference DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689S–1696SPubMed DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689S–1696SPubMed
19.
go back to reference Banerjee P, Chatterjee M (2003) Antiproliferative role of vitamin D and its analogs–a brief overview. Mol Cell Biochem 253(1–2):247–254CrossRefPubMed Banerjee P, Chatterjee M (2003) Antiproliferative role of vitamin D and its analogs–a brief overview. Mol Cell Biochem 253(1–2):247–254CrossRefPubMed
20.
go back to reference Hickish T, Cunningham D, Colston K et al (1993) The effect of 1, 25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 68(4):668–672PubMed Hickish T, Cunningham D, Colston K et al (1993) The effect of 1, 25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 68(4):668–672PubMed
21.
go back to reference Raina V, Cunningham D, Gilchrist N, Soukop M (1991) Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 63(3):463–465PubMed Raina V, Cunningham D, Gilchrist N, Soukop M (1991) Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 63(3):463–465PubMed
22.
go back to reference Chang ET, Balter KM, Torrang A et al (2006) Nutrient intake and risk of non-Hodgkin’s lymphoma. Am J Epidemiol 164(12):1222–1232CrossRefPubMed Chang ET, Balter KM, Torrang A et al (2006) Nutrient intake and risk of non-Hodgkin’s lymphoma. Am J Epidemiol 164(12):1222–1232CrossRefPubMed
23.
go back to reference Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 17(4):713–718CrossRefPubMed Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 17(4):713–718CrossRefPubMed
24.
go back to reference Purdue MP, Hartge P, Davis S et al (2007) Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control 18(9):989–999CrossRefPubMed Purdue MP, Hartge P, Davis S et al (2007) Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control 18(9):989–999CrossRefPubMed
25.
go back to reference Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98(7):451–459CrossRefPubMed Giovannucci E, Liu Y, Rimm EB et al (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98(7):451–459CrossRefPubMed
26.
go back to reference Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99(21):1594–1602CrossRefPubMed Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99(21):1594–1602CrossRefPubMed
27.
go back to reference Lim U, Freedman DM, Hollis BW et al (2009) A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 124(4):979–986CrossRefPubMed Lim U, Freedman DM, Hollis BW et al (2009) A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 124(4):979–986CrossRefPubMed
28.
go back to reference Erber E, Maskarinec G, Lim U, Kolonel LN (2009) Dietary vitamin D and risk of non-Hodgkin lymphoma: the multiethnic cohort. Br J Nutr 103(4):581–584CrossRefPubMed Erber E, Maskarinec G, Lim U, Kolonel LN (2009) Dietary vitamin D and risk of non-Hodgkin lymphoma: the multiethnic cohort. Br J Nutr 103(4):581–584CrossRefPubMed
30.
go back to reference Tanner JT, Smith J, Defibaugh P et al (1988) Survey of vitamin content of fortified milk. J Assoc Off Anal Chem 71(3):607–610PubMed Tanner JT, Smith J, Defibaugh P et al (1988) Survey of vitamin content of fortified milk. J Assoc Off Anal Chem 71(3):607–610PubMed
31.
go back to reference Harris NL, Jaffe ES, Diebold J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835–3849PubMed Harris NL, Jaffe ES, Diebold J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835–3849PubMed
32.
go back to reference Kulak CA, Borba VZ, Bilezikian JP et al (2004) Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 62(4):940–948PubMed Kulak CA, Borba VZ, Bilezikian JP et al (2004) Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 62(4):940–948PubMed
33.
go back to reference Holick MF, Siris ES, Binkley N et al (2005) Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90(6):3215–3224CrossRefPubMed Holick MF, Siris ES, Binkley N et al (2005) Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90(6):3215–3224CrossRefPubMed
34.
go back to reference Brown LM, Hoover R, Gridley G et al (1997) Drinking practices and risk of squamous-cell esophageal cancer among Black and White men in the United States. Cancer Causes Control 8(4):605–609CrossRefPubMed Brown LM, Hoover R, Gridley G et al (1997) Drinking practices and risk of squamous-cell esophageal cancer among Black and White men in the United States. Cancer Causes Control 8(4):605–609CrossRefPubMed
35.
go back to reference Brown LM, Pottern LM, Silverman DT et al (1997) Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beverages. Cancer Causes Control 8(4):610–614CrossRefPubMed Brown LM, Pottern LM, Silverman DT et al (1997) Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beverages. Cancer Causes Control 8(4):610–614CrossRefPubMed
36.
go back to reference Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL (1993) Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 39(3):529–533PubMed Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL (1993) Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 39(3):529–533PubMed
37.
go back to reference Stolzenberg-Solomon RZ, Hayes RB, Horst RL et al (2009) Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 69(4):1439–1447CrossRefPubMed Stolzenberg-Solomon RZ, Hayes RB, Horst RL et al (2009) Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 69(4):1439–1447CrossRefPubMed
38.
go back to reference Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lipincott-Raven Publishers, Philadelphia, PA Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lipincott-Raven Publishers, Philadelphia, PA
39.
go back to reference Millen AE, Bodnar LM (2008) Vitamin D assessment in population-based studies: a review of the issues. Am J Clin Nutr 87(4):1102S–1105SPubMed Millen AE, Bodnar LM (2008) Vitamin D assessment in population-based studies: a review of the issues. Am J Clin Nutr 87(4):1102S–1105SPubMed
40.
go back to reference Brot C, Vestergaard P, Kolthoff N et al (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 86(1):S97–S103CrossRefPubMed Brot C, Vestergaard P, Kolthoff N et al (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 86(1):S97–S103CrossRefPubMed
41.
go back to reference Al-Delaimy WK, Jansen EH, Peeters PH et al (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11(4):370–382CrossRefPubMed Al-Delaimy WK, Jansen EH, Peeters PH et al (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11(4):370–382CrossRefPubMed
42.
go back to reference Davies M, Hayes ME, Yin JA, Berry JL, Mawer EB (1994) Abnormal synthesis of 1, 25-dihydroxyvitamin D in patients with malignant lymphoma. J Clin Endocrinol Metab 78(5):1202–1207CrossRefPubMed Davies M, Hayes ME, Yin JA, Berry JL, Mawer EB (1994) Abnormal synthesis of 1, 25-dihydroxyvitamin D in patients with malignant lymphoma. J Clin Endocrinol Metab 78(5):1202–1207CrossRefPubMed
43.
go back to reference Morton LM, Wang SS, Cozen W et al (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112(13):5150–5160CrossRefPubMed Morton LM, Wang SS, Cozen W et al (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112(13):5150–5160CrossRefPubMed
44.
go back to reference Evens AM, Chiu BC (2008) The challenges of epidemiologic research in non-Hodgkin lymphoma. JAMA 300(17):2059–2061CrossRefPubMed Evens AM, Chiu BC (2008) The challenges of epidemiologic research in non-Hodgkin lymphoma. JAMA 300(17):2059–2061CrossRefPubMed
45.
go back to reference Garland CF, Grant WB, Mohr SB, Gorham ED, Garland FC (2007) What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev 65(8 Pt 2):S91–S95CrossRefPubMed Garland CF, Grant WB, Mohr SB, Gorham ED, Garland FC (2007) What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev 65(8 Pt 2):S91–S95CrossRefPubMed
46.
go back to reference Crew KD, Gammon MD, Steck SE et al (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila Pa) 2(6):598–604 Crew KD, Gammon MD, Steck SE et al (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila Pa) 2(6):598–604
48.
go back to reference Vermeer M, Schmieder GJ, Yoshikawa T et al (1991) Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol 97(4):729–734CrossRefPubMed Vermeer M, Schmieder GJ, Yoshikawa T et al (1991) Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol 97(4):729–734CrossRefPubMed
49.
go back to reference Hersey P, Bradley M, Hasic E et al (1983) Immunological effects of solarium exposure. Lancet 1(8324):545–548CrossRefPubMed Hersey P, Bradley M, Hasic E et al (1983) Immunological effects of solarium exposure. Lancet 1(8324):545–548CrossRefPubMed
50.
go back to reference Melbye M, Adami HO, Hjalgrim H, Glimelius B (1996) Ultraviolet light and non-Hodgkin’s lymphoma. Acta Oncol 35(6):655–657CrossRefPubMed Melbye M, Adami HO, Hjalgrim H, Glimelius B (1996) Ultraviolet light and non-Hodgkin’s lymphoma. Acta Oncol 35(6):655–657CrossRefPubMed
51.
go back to reference Fisher SG, Fisher RI (2006) The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol 18(5):417–424CrossRefPubMed Fisher SG, Fisher RI (2006) The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol 18(5):417–424CrossRefPubMed
52.
go back to reference Engels EA (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):401–404CrossRefPubMed Engels EA (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):401–404CrossRefPubMed
53.
go back to reference Steindal AH, Porojnicu AC, Moan J (2007) Is the seasonal variation in cancer prognosis caused by sun-induced folate degradation? Med Hypotheses 69(1):182–185CrossRefPubMed Steindal AH, Porojnicu AC, Moan J (2007) Is the seasonal variation in cancer prognosis caused by sun-induced folate degradation? Med Hypotheses 69(1):182–185CrossRefPubMed
Metadata
Title
A case–control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults
Authors
Jennifer L. Kelly
Jonathan W. Friedberg
Laura M. Calvi
Edwin van Wijngaarden
Susan G. Fisher
Publication date
01-08-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 8/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9554-1

Other articles of this Issue 8/2010

Cancer Causes & Control 8/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine